Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

Summary Background Most patients with extensive stage small-cell lung cancer (ES-SCLC) who undergo chemotherapy, and prophylactic cranial irradiation, have persistent intrathoracic disease. We assessed thoracic radiotherapy for treatment of this patient group. Methods We did this phase 3 randomised...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2015-01, Vol.385 (9962), p.36-42
Hauptverfasser:	Slotman, Ben J, MD, van Tinteren, Harm, PhD, Praag, John O, MD, Knegjens, Joost L, MD, El Sharouni, Sherif Y, MD, Hatton, Matthew, FRCR, Keijser, Astrid, MSc, Faivre-Finn, Corinne, PhD, Senan, Suresh, FRCR
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Belgium Cancer therapies Chemotherapy Clinical trials Disease-Free Survival Drug dosages Female Humans Internal Medicine Irradiation Lung cancer Lung Neoplasms - radiotherapy Male Metastasis Middle Aged Netherlands Norway Radiation therapy Secondary analysis Small Cell Lung Carcinoma - radiotherapy Survival Treatment Outcome United Kingdom
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!